A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children

A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children: Antiseptic Cream Alone v's Antiseptic Cream With Nasal Cautery

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00390663

Enrollment

216

Registered

2006-10-20

Start date

2006-10-31

Completion date

Unknown

Last updated

2006-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis

Keywords

Paediatric, Epistaxis, Nose bleed, Naseptin

Brief summary

To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recurrent paediatric epistaxis.

Interventions

PROCEDURENasal Cautery

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

1 Years to 14 Years

Healthy volunteers

Inclusion criteria

* Children aged 1 - 14 * History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to attending the ENT clinic. * Presence of prominent vessels on the anterior nasal septum on the side that reportedly bleeds (or on at least one side if bleeding is reported to be bilateral)

Exclusion criteria

* No prominent vessels on examination (these children will be randomised but will be prescribed Naseptin alone and followed up in the same way as the children in the trial, for completeness of data) * Known bleeding disorders. * Allergy to peanuts, neomycin or chlorhexidine * Other causes of nose bleeding eg tumour.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026